Temporal effects of exposure to sublethal, total-body X radiation (400 R) on responses to vaccination with the attenuated Venezuelan equine encephalomyelitis vaccine virus, TC-83, were examined in rhesus monkeys. Viremia, often with delayed onset, was prolonged even when irradiation preceded vaccination by 28 days. Virus titers were increased, particularly in groups irradiated 4 or 7 days before vaccination. Delay in appearance of hemagglutination-inhibition and serum-neutralizing antibody correlated closely with persistence of viremia in irradiated-vaccinated monkeys. The 14 days, undoubtedly contributed to this increased susceptiblility to latent infection.
After various immunosuppressive measures, both potentiation (9, 14, 16, 19, 20, 34, 35) and nonpotentiation (11, 13, 20, 22) of experimentally induced virus infections have been described, but these phenomena have received little attention in irradiated monkeys. The most pertinent study of Syverton et al. (31) revealed decreased resistance of irradiated monkeys to infection with poliomyelitis virus, with earlier onset and longer persistence of viremia and increased fatality rates. In other related studies, the appearance of circulating antibody was delayed in irradiated monkeys immunized with either typhoid vaccine or sheep erythrocytes (23) , findings consistent with responses observed in analogous studies with rodents (25, 30, 32) . Another report (4) inhibition (HI) antibody in rhesus monkeys irradiated 24 h before VEE immunization. However, the latter study did not examine the temporal relationship of irradiation to vaccination (21) .
Because of the increased use of live vaccines to control viral infections, the temporal relationship between irradiation and live vaccination in monkeys was of particular interest. Further, TC-83, developed as a vaccine for human use (1) and subsequently used in animals during recent epizootics (27, 28) , was selected because prior studies in mice suggested that there may be a close correlation between persistence of this live, viral antigen and the primary humoral antibody response of an irradiated host (29) .
were irradiated while in plastic cylinders rotated at 2 rpm. Exposure dose was measured in air with a recently calibrated Victoreen condenser R-chamber.
Virus. The attenuated, live VEE virus, TC-83, has been described previously (3, 18) . TC-83 vaccine, lot 3 (Merrell-National Laboratories, Division of Richardson-Merrell, Inc., Swiftwater, Pa.) was reconstituted with 1.2 ml of Hanks balanced salt solution. Monkeys were vaccinated subcutaneously with a 0.4-ml dose containing approximately 5 x 104 plaque-forming units (PFU) of virus as titrated with Vero cell cultures.
Experimental design. Three replicate experiments were conducted. In each experiment, monkeys were inoculated with TC-83 vaccine on the same day; consequently, irradiation was accomplished at varying times before inoculation. Monkeys were allocated randomly into six experimental groups, a vaccine control (VC) group and a radiation control (RC) group; experimental groups were irradiated at 2 h or 1, 4, 7, 14, or 28 days before vaccination (R-2h, R-1, R-4, R-7, R-14, R-28). All monkeys were bled by femoral venipuncture for 5 consecutive days before irradiation to establish base-line values for complete blood count, hematocrit, and platelets. After irradiation, blood samples were collected periodically to monitor hematopoietic depression.
After vaccination, monkeys were bled every 8 h for 3 days, daily for the next 18 days, twice a week for 4 weeks, and once a week for 4 additional weeks to collect serum and whole blood. Bleedings were done at the same time each day. All sera were stored at -70 C until assayed.
Viremia assay. Sera were assayed for virus content with Vero cell cultures by a microtiter method (8 
RESULTS
Infection with TC-83 virus. Time of appearance, duration, and peak titer of virus in samples of peripheral blood were determined for nonirradiated and irradiated groups of monkeys (Table 1 ). Only five of eight nonirradiated VC monkeys developed detectable levels of viremia ( > 102 PFU/ml); the first positive samples were recovered at 40 to 64 h postinoculation. Viremia was of brief duration, never more than 32 h, but was variable in magnitude; maximum titers ranged from 440 to 40,000 PFU/ml.
In contrast, except for three monkeys irradiated 28 days before vaccination, no. R-28-F, G, and H, all irradiated-vaccinated monkeys became viremic (Table 1 ). In some, however, particularly in the group irradiated 1 day preinoculation, development of detectable viremia was delayed; in one monkey (no. R-1-D), it was delayed for as long as 11 days. Persistence of viremia was prolonged in all irradiated groups; the greatest prolongation, 8 to 9 days, occurred in groups irradiated 1 or 4 days before vaccination. A bimodal pattern with two viremia peaks, often separated by several days, was observed in 13 of 37 irradiated monkeys. Maximum viremia titers in the 4-and 7-day irradiation groups were extremely variable, but their group means were significantly higher (P < 0.05) than the mean titer for the VC group. Unlike the three monkeys in the VC group that failed to develop detectable viremia, the three nonviremic monkeys in the 28-day group also failed to develop specific antibodies.
Prolonged viremia probably was not associated with delayed clearance of the viral inoculum by the reticuloendothelial system (RES) because vascular clearance of 1 ml (109 PFU) of TC-83 was not significantly different for irradiated and nonirradiated monkeys (12 (Fig. 1A) . A marked lymphopenia to 10 to 20% of normal levels developed within 24 to 48 h and was maintained for 17 to 20 days after 400 R of total-body irradiation exposure. Likewise, in nonirradiated monkeys vaccinated with TC-83, a slight decrease in total peripheral lymphocytes consistently occurred within 3 to 5 days, but was of lesser degree, generally 75 to 80% of normal levels.
The extent and duration of lymphocyte depression in all RC and irradiated-vaccinated monkeys were similar during the first 20 days after irradiation (Fig. 1A, B, C) . Subsequently, the recovery pattern for lymphocyte response depended upon the temporal relationship of irradiation to vaccination. Monkeys irradiated 4 days before vaccination exhibited a lymphocyte response pattern similar to that of the RC group (Fig. la) , whereas monkeys in the R-1 and R-7 groups showed earlier recovery of peripheral lymphocytes (Fig. 1B, C) . In contrast, lymphocyte recovery patterns for monkeys in the R-14 and R-28 groups remained somewhat depressed for as long as 50 to 60 days postirradiation (Fig.  1B, C) . Monkeys in the R-14 group that died within 20 days postvaccination generally showed no evidence of significant recovery of lymphocyte counts and many manifested a gradual decrease to below 0.1 to 0.2 of normal.
Antibody responses. Except for three previously described monkeys in the R-28 group, all surviving vaccinees developed HI and neutralizing antibodies. Generally, antibody was detected within 1 to 3 days after termination of detectable viremia, and neutralizing activity appeared 1 to 2 days before HI antibodies, possibly reflecting the 10-fold greater sensitivity of the PRN assay.
Comparisons of group mean values for HI response patterns are shown in Fig. 2 and for PRN response patterns in Fig. 3 . Detectable antibody appeared more slowly in irradiatedvaccinated groups than in the VC group; delays of 3 to 5 days in the initial appearance of neutralizing antibody and of 4 to 7 days in that of HI antibody were observed. Temporal differences in time of appearance for group responses appeared to be related to mean time of maximum viremia as well as to mean duration of viremia. The shortest delay for both antibody activities (3 and 4 days, respectively) occurred in the R-7 group. Except for the HI response of group R-28, the rate of increase for both activities was somewhat slower for irradiated-vaccinated groups than for the VC group, resulting in a delay in achieving maximum antibody titers. The maximum mean HI titer occurred on day 15 after vaccination for the VC group, and on day 18 for group R-28, but was 2 to 3 weeks later for groups R-4, R-7, and R-14, and 5 to 6 weeks later for group R-1.
Unlike the relatively short-lived peak responses for VC, R-4, and R-7 groups, titers for R-1, R-14, and R-28 remained at maximum levels for at least 6 weeks. The time for maximum neutralizing activity was delayed for all irradiated-vaccinated groups; maximum titer was achieved on day 17 for VC monkeys, 2 to 3 weeks later for groups R-1, R-4, and R-7, and 5 to 7 weeks later for R-14 and R-28. There was suggestive evidence for a biphasic PRN response for VC monkeys with a second maximum approximately 4 weeks after the first. Response patterns for irradiated-vaccinated groups showed no biphasic trend; R-1, R-4, and R-7 patterns gradually decreased from peak values, and R-14 and R-28 responses remained at approximately maximum levels until termination of the study.
DISCUSSION
Our findings with monkeys exposed to 400 R of sublethal, total-body X-irradiation from 2 h to 28 days prior to vaccination with the attenuated TC-83 strain of VEE clearly indicate that the temporal relationship between irradiation and vaccination has a significant effect on development, magnitude, and persistence of viremia and on antibody response patterns. Although parameters of the viremic response are accentuated in all irradiated groups, delays in onset of detectable viremia, persistence of virus and time required for development of maximum virus titers in the blood are particularly notable in groups irradiated 1 the remaining monkeys in the group do not substantiate this assumption. Moreover, although irradiation or immunosuppressive drugs predispose animals to low-dose tolerance with relative ease (7, 17) , development of immune tolerance with other viral immunogens has INFECT. IMMUN.
on October 25, 2017 by guest http://iai.asm.org/ Downloaded from invariably followed a viremic episode (6) .
Persistence of viremia has been reported with other viruses in irradiated monkeys (31) and in immunosuppressed rodents (19) ; in the latter, an increase in tissue levels of virus was also observed. This deficiency in capability of irradiated animals to limit or suppress proliferation of viable antigen might result from suppression of antibody production, interferon production, or from delay in clearance by the RES (9, 26, 32) . In the present studies, vaccinated-irradiated monkeys, unlike vaccinated controls, failed to develop measurable levels of interferon in their blood, suggesting that a deficiency of interferon may be a contributory factor. Initial clearance of inoculated virus by the RES, however, was essentially the same in both groups.
It is conceivable that depressed RES clearance is partly responsible for persistence of virus in the blood. Although it is reported that consequences of irradiation may either increase, decrease, or not change RES clearance in small nonprimate species (26), our preliminary TC-83 clearance studies in monkeys indicated that neither total body irradiation nor RES blockade with colloidal carbon delayed initial RES clearance of virus (12) . Wagner et al. (33) found that vascular clearance of aggregated albumin in man was delayed in experimental viral infections; therefore, prolonged viremia in irradiated, TC-83-infected monkeys may still be due in part to delayed RES clearance of virus during infection.
The delay in the onset of detectable viremia in some irradiated monkeys suggest a deficient, susceptible, target-cell population and consequent slow development of detectable levels of viremia. Cells undergoing rapid cell division tend to be more radiosensitive, and VEE virus has known radiomimetic, particularly lympholytic, properties (2, 10 3A) , we attribute the deaths of eight animals in the R-14 group to the radiomimetic stress of TC-83 superimposed on an already severely depressed hematopoietic capability at a critical time.
The initial delay in observable antibody in the irradiated monkeys correlates closely with the prolongation of viremia and magnitude of antibody response with antigenic mass (course of viremia) as well. The temporal studies clearly illustrate that, at a critical time after irradiation, the capability of the host to respond to a replicating antigen changes from a somewhat depressed state to relatively normal or enhanced activity. In contrast with nonreplicating antigens, enhancement of antibody has generally been reported when antigen injection precedes irradiation by a few hours (32), although Bogden et al. (4) found enhancement of immunological response in monkeys when irradiation preceded antigen injection.
It has been reported that a prolonged latent period in antibody development followed by a normal or enhanced antibody response is indicative of inhibition of the antibody-synthesizing mechanism, i.e., the proliferation and maturation of antibody-forming cells, without affecting induction (antigen recognition). In contrast, a decreased antibody response is interpreted as a depression of both induction and antibody synthesis mechanisms (4, 32) . In this study, the HI antibody titers of monkeys in the R-1 group (Fig. 1A) were depressed and the latent period was prolonged; this could be interpreted as depression of both the induction-and antibodysynthesizing phases. Monkeys from the R-4 and R-7 groups showed near-normal or above-normal HI and serum-neutralizing titers, suggesting that the induction phase was not affected greatly, but that depression of the synthesizing mechanism may have been responsible for the prolonged latent period. This is consistent with interpretations of others in studies with a nonreplicating antigen in irradiated monkeys (4) .
The induction phase may have been affected even more severely in our studies than is borne out by the data, because prolonged antigenic stimulation and/or exposure to increased antigenic mass through viral replication in the host probably contributed significantly to the HI and serum-neutralizing antibody responses.
Other explanations for enhanced immune response in this situation may include depletion of T cells (thymus-dependent lymphocytes) that would normally exert a suppressive, regulatory influence on B-lymphocyte subpopulations (15) .
Another effect by sublethal, total-body irradi- 
